跳至主要内容
临床试验/NCT03692858
NCT03692858Unknown2 期

IPACK Block Efficacy as a Part of Multimodal Analgesia in Total Knee Arthroplasty. A Prospective, Randomized, Controlled, Double Blinded Study

Asklepieion Voulas General Hospital1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2018年10月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
发起方
入组人数
100
试验地点
1
主要终点
NRS scores

研究概览

简要总结

100 patients ASA I-III, undergoing total knee arthroplasty under spinal anesthesia, will be randomly assigned into one of two groups, namely group A (n=50), where an adductor canal block and an IPACK block will be performed preoperatively and group B (n=50) where an adductor canal block only will be performed preoperatively. All patients will receive a standardized multimodal approach, including pregabalin, paracetamol, and PCA with morphine. NRS scores in static and dynamic conditions during the first 48 hours postoperatively, morphine consumption during the first 24 hours postoperatively will be measured and additionally, patient satisfaction, complications, range of knee motion, moblization, functionality, delirium ocurence will be recorded. Chronic pain will be assessed in 3 and 6 months postoperatively.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
14 Years 至 80 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Physical status according to American Society of Anesthesiologists (ASA) I-III
  • Patients scheduled for total knee arthroplasty

排除标准

  • Previous operation on same knee
  • Contraindication of spinal anesthesia, peripheral nerve blocks or any of the agents used in the protocol
  • BMI above 32
  • Serious psychiatric, mental and cognitive disorders
  • Language barrier
  • Block failure
  • Chronic opioid, gabapentinoid use
  • Severe kidney disfunction

研究组 & 干预措施

Group A

Active Comparator

干预措施: Adductor Canal Block plus IPACK Block (Drug)

Group B

Active Comparator

干预措施: Adductor Canal Block (Drug)

结局指标

主要结局

NRS scores

时间窗: 48 hours

Numerical Rating Scale (NRS) scores (Range 0-10, 0=no pain, 10=the worse pain ever)

Morphine consumption

时间窗: 24 hours

Morphine consumption in mg

Chronic pain

时间窗: 6 months

Using of Graded Chronic Pain Scale (GCPS) Grade 0: No pain in prior 6 months Grade 1: Low Intensity - Low Disability Grade II: High Intensity Characteristic Pain Intensity - Low Disability Grade III: High Disability - Moderately Limiting Grade IV: High Disability - Severely Limiting

次要结局

  • Complications(48 hours)
  • Patient satisfaction(48 hours)
  • Intestinal function(5 days)
  • Patient mobilization(5 days)
  • Range of knee motion(48 hours)
  • Delirium occurence(48 hours)
  • Joint function(6 months)

研究者

发起方
Asklepieion Voulas General Hospital
申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Alexandros Makris

Consultant Anesthesiologist

Asklepieion Voulas General Hospital

研究点 (1)

Loading locations...

相似试验